Insiders Updates
Goldman analysts upgrades a Neutral rating for Ionis Pharmaceuticals Inc (IONS)
In a filing, Ionis Pharmaceuticals Inc revealed its EVP CLO & General Counsel O’NEIL PATRICK R. unloaded Company’s shares for
Menu
In a filing, Ionis Pharmaceuticals Inc revealed its EVP CLO & General Counsel O’NEIL PATRICK R. unloaded Company’s shares for
In a filing, Ionis Pharmaceuticals Inc revealed its EVP CLO & General Counsel O’NEIL PATRICK R. unloaded Company’s shares for
Ionis Pharmaceuticals Inc’s filing revealed that its EVP Research Swayze Eric unloaded Company’s shares for reported $0.55 million on Sep
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Ionis Pharmaceuticals Inc revealed its Director PARSHALL B LYNNE unloaded Company’s shares for reported $0.21 million on
Ionis Pharmaceuticals Inc’s recently made public that its Officer Schneider Eugene acquired Company’s shares for reported $0.41 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or